Immunosenescence and inflammaging: from pathological hallmarks to rejuvenation strategies
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 07.05.2026 · 81 (6)
DOI: 10.1093/gerona/glag108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 24.04.2026. Verfasst von Yaoli Hou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Administration, the Second Affiliated Hospital, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Immunosenescence, Rejuvenation, Inflammation, Aging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Immunosenescence—the age-related decline of immune function—drives a state of chronic, sterile inflammation termed inflammaging. Far from passive deterioration, this process is actively orchestrated by distinct but interconnected hallmarks: erosion of lymphoid organs, myeloid-biased hematopoiesis, accumulation of immune-evasive senescent cells, and metabolic-epigenetic reprogramming that locks cells into dysfunctional states. These core nodes form a self-perpetuating cycle that propagates pathology across multiple organ systems, fueling neurodegeneration, cancer, musculoskeletal decline, and gut dysbiosis. Critically, the field has transitioned from descriptive phenomenology to mechanism-based intervention. This review synthesizes emerging therapeutic strategies targeting specific nodes of the immunosenescence network. We examine senotherapeutics that sensitize senescent cells for immune clearance, HSC and thymic rejuvenation to restore lymphocyte production, and metabolic-epigenetic interventions to correct intracellular deficits. By integrating these insights, we propose a precision medicine framework that moves beyond broad immunosuppression toward rational combinatorial regimens. This roadmap aims to decouple protective immunity from pathological drivers, extending healthspan and redefining the paradigm of geriatric care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Administration, the Second Affiliated Hospital, University of South China, Hengyang, China.
- Department of Anesthesiology, the Second Affiliated Hospital, University of South China, Hengyang, China.
- Hengyang Medical School, University of South China, Hengyang, China.
- Department of Anesthesiology, the First Affiliated Hospital, University of South China, Hengyang, China.
ORCID-Profile: Ren Jing
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Science and Technology Program
Zitieren
APA
Hou, Y., Zeng, Z., He, S., He, L., Liu, K., Tang, W., Wang, D., Gui, J., Wang, Y., Liu, W., & Jing, R. (2026). Immunosenescence and inflammaging: from pathological hallmarks to rejuvenation strategies. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(6). https://doi.org/10.1093/gerona/glag108
Vancouver
Hou Y, Zeng Z, He S, He L, Liu K, Tang W, et al. Immunosenescence and inflammaging: from pathological hallmarks to rejuvenation strategies. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(6). doi:10.1093/gerona/glag108
BibTeX
@article{Hou2026,
author = {Hou, Yaoli and Zeng, Zhiying and He, Sheng and He, Lili and Liu, Kun and Tang, Wen and Wang, Deming and Gui, Jing and Wang, Yan and Liu, Wenjie and Jing, Ren},
title = {Immunosenescence and inflammaging: from pathological hallmarks to rejuvenation strategies},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/gerona/glag108}
}
EUVIMED